An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriers. - Osorio, A.; Pollán, M.; Pita, G.; Schmutzler, R. K.; Versmold, B.; Engel, C.; Meindl, A.; Arnold, N.; Preisler-Adams, S.; Niederacher, D.; Hofmann, W.; Gadzicki, D.; et al. (British Journal of Cancer, 2008)